Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

hydrogen

hydrogen is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 2
Pipeline programs 12
News articles 0
Drug details — hydrogen
Class
—
Route
—
Patents
2
Programs
12
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

hydrogen is an FDA-listed pharmaceutical active ingredient.

Key facts

INN hydrogen

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. DR200091 Phase 3 · Tour Hekla · Thrombotic episodes in superficial venous malformations in c
  2. APHP230821 Phase 2 · PARItec · NEUROENDOCRINE CELLS HYPERPLASIA OF INFANCY
  3. Hydrogen Peroxide Phase 2 · United Therapeutics Europe · Breast Cancer
  4. Lumevoq Phase 2 · GenSight Biologics · Leber Hereditary Optic Neuropathy due to mutations in the mi
  5. RAVICTI 1.1 g/ml oral liquid Phase 2 · PARItec · Pyruvate dehydrogenase deficiency
  6. Sodium phenylbutyrate Phase 2 · ZEVRA THERAPEUTICS · Medium-chain Acyl-CoA Dehydrogenase Deficiency
  7. Triheptanoin Phase 2 · Ultragenyx UK · Medium-chain Acyl-CoA Dehydrogenase Deficiency
  8. UC-GIG-2308 Phase 2 · Ningbo Cancer Hospital · Patients with pMMR/MSS metastatic adenocarcinoma of the colo

Related patents

Browse patents

  1. US 20260125398

    5,6-FUSED BICYCLIC ALCOHOL COMPOUNDS AS 15-PROSTAGLANDIN DEHYDROGENASE MODULATORS

    Expires Wed May 02 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. PT 2303855

    CATALYTIC PROCESS FOR ASYMMETRIC HYDROGENATION

    Expires Tue Mar 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is hydrogen?

hydrogen is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.